inhibitors trang 4 tải miễn phí từ TAILIEUCHUNG

"inhibitors" trang 4 - tải miễn phí từ Tailieuchung

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

12 41 1

Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma

Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma

4 48 1

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

9 20 1

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

12 30 1

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: A report from population-based Lithuanian haematological disease registry 2000–2013

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: A report from population-based Lithuanian haematological disease registry 2000–2013

10 24 1

Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy

Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy

9 49 1

Pathogenesis of SARS-CoV-2 and important insights on its potent inhibitors remdesivir and chloroquine - A review

Pathogenesis of SARS-CoV-2 and important insights on its potent inhibitors remdesivir and chloroquine - A review

11 65 1

5α-reductase inhibitors impact prognosis of urothelial carcinoma

5α-reductase inhibitors impact prognosis of urothelial carcinoma

7 25 1

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

9 36 1

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

11 42 1

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

13 63 1

Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer

Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer

9 40 1

E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors

E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors

11 43 1

Efflux pumps and these inhibitors

Efflux pumps and these inhibitors

11 33 1

Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases

Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases

12 42 1

Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana

Cheminformatic models based on machine learning for pyruvate kinase inhibitors of Leishmania mexicana

7 41 1

Questionnaire-based detection of immunerelated adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

Questionnaire-based detection of immunerelated adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

10 32 1

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

9 28 1

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: Long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: Long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors

12 19 1

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function

10 28 1

Đầu
1
2
3
[ 4 ]
5
6
7
8
9
10
11
12
13
14
15
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.